MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss available
to common...
-$33,664K
Net loss
-$33,560K
(-54.21%↓ Y/Y)
Warrant deemed dividend
$104K
Gain from change in
fair value of warrant...
-$24,441K
(-299.04%↓ Y/Y)
Interest income, net
$105K
(-80.91%↓ Y/Y)
Loss on issuance of
warrant liabilities
-$30,962K
(-3555.49%↓ Y/Y)
Loss from operations
-$25,103K
(5.77%↑ Y/Y)
Transaction costs allocated
to warrant...
$1,407K
(41.69%↑ Y/Y)
Loss on
extinguishment of warrant...
-$614K
Other (expense)
income, net
-$20K
(-146.51%↓ Y/Y)
Total operating
expenses
$25,103K
(-5.77%↓ Y/Y)
Research and development
$15,891K
(-10.37%↓ Y/Y)
General and
administrative
$9,122K
(3.82%↑ Y/Y)
Depreciation and
amortization
$90K
(-28.57%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Moleculin Biotech, Inc. (MBRX)
Moleculin Biotech, Inc. (MBRX)